This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Tobacco Use Disorder
Information about Tobacco Use Disorder: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Tobacco Use Disorder
Most recent studies have shown that Tobacco Use Disorder shares some biological mechanisms with addictive-behavior, anxiety-disorders, cardiovascular-diseases, depressive-disorder, lung-neoplasms, malignant-neoplasm-of-lung, malignant-neoplasms, mental-disorders, neoplasms, nicotine-dependence, schizophrenia, substance-related-disorders, substance-withdrawal-syndrome, tobacco-dependence-syndrome, withdrawal-sign-or-symptom.
Among the many pathways, these few ones have gauged particular interests from scientists studying Tobacco Use Disorder, and have been seen in publications frequently: Aging, Associative Learning, Cognition, Habituation, Hypersensitivity, Locomotion, Menopause, Pathogenesis, Prepulse Inhibition, Reflex, Response To Drug, Response To Nicotine, Response To Stress, Secretion, Segmentation, Sensitization, Startle Response, Translation, Transport, Vasoconstriction
Quite a number of genes have been found to play important roles in Tobacco Use Disorder, such as BDNF, CHRNA3, CHRNA4, CHRNA5, CHRNB4, CNR1, COMT, CYP2A6, DRD2, HOMER2, NDP, NDUFB6, SCTR, SLC6A3, SLC6A4, SNCG, TEAD1, TLR4. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.